The effect of weight on exposure in hepatitis C: Peginterferon alfa-2b and peginterferon alfa-2a

被引：0
|
作者：
Silva, M
Cutler, D
Poo-Ramirez, JL
Wagner, F
Jackson, M
Cullen, C
机构：
来源：
GASTROENTEROLOGY | 2005年 / 128卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A723 / A723
页数：1
相关论文
共 50 条
  • [1] Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Hepatitis C
    Hsu, Ching-Sheng
    Kao, Jia-Horng
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (18): : 1808 - 1809
  • [2] Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Hepatitis C REPLY
    Albrecht, Janice
    McHutchison, John
    Sulkowski, Mark
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (18): : 1809 - 1809
  • [3] Peginterferon alfa-2b vs. peginterferon alfa-2a in the treatment of hepatitis C, is there any difference?
    Sierra, Fernando
    [J]. JOURNAL OF HEPATOLOGY, 2007, 46 (02) : 349 - 349
  • [4] Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection
    McHutchison, John G.
    Lawitz, Eric J.
    Shiffman, Mitchell L.
    Muir, Andrew J.
    Galler, Greg W.
    McCone, Jonathan
    Nyberg, Lisa M.
    Lee, William M.
    Ghalib, Reem H.
    Schiff, Eugene R.
    Galati, Joseph S.
    Bacon, Bruce R.
    Davis, Mitchell N.
    Mukhopadhyay, Pabak
    Koury, Kenneth
    Noviello, Stephanie
    Pedicone, Lisa D.
    Brass, Clifford A.
    Albrecht, Janice K.
    Sulkowski, Mark S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (06): : 580 - 593
  • [5] Antiviral effect of peginterferon alfa-2b and alfa-2a compared
    Jansen, Peter L. M.
    Reesink, Henk W.
    [J]. JOURNAL OF HEPATOLOGY, 2006, 45 (02) : 172 - 173
  • [6] Peginterferon alfa-2a/ribavirin in hepatitis C virus patients nontolerant or nonresponsive to peginterferon alfa-2b/ribavirin
    Rustgi, V. K.
    Esposito, S.
    Hamzeh, F. M.
    Shiffman, M. L.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (05) : 433 - 440
  • [7] Pharmacoeconomic analysis of the treatment of chronic hepatitis C with peginterferon alfa-2a or peginterferon alfa-2b plus ribavirin in Spain
    Turnes, Juan
    Romero-Gomez, Manuel
    Planas, Ramon
    Sola, Ricard
    Garcia-Samaniego, Javier
    Diago, Moises
    Crespo, Javier
    Calleja, Jose Luis
    Rubio-Terres, Carlos
    Ventayol, Pere
    [J]. GASTROENTEROLOGIA Y HEPATOLOGIA, 2013, 36 (09): : 555 - 564
  • [8] Clinical and persistency outcomes in hepatitis C patients treated with peginterferon alfa-2a or peginterferon alfa-2b plus ribavirin
    Hassanein, T. I.
    Ye, X.
    Blumentals, W. A.
    Brixner, D. I.
    [J]. JOURNAL OF HEPATOLOGY, 2008, 48 : S295 - S296
  • [9] Pharmacodynamics of peginterferon alfa-2a and peginterferon alfa-2b in interferon-naive patients with chronic hepatitis C: a randomized, controlled study
    Bruno, R.
    Sacchi, P.
    Scagnolari, C.
    Torriani, F.
    Maiocchi, L.
    Patruno, S.
    Bellomi, F.
    Filice, G.
    Antonelli, G.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (03) : 369 - 376
  • [10] Dynamics of Apoptotic Activity in Patients With Chronic Hepatitis C Treated With Albinterferon Alfa-2B or Peginterferon Alfa-2a
    Kronenberger, Bernd
    Herrmann, Eva
    Chen, C.
    Fiscella, M.
    Subramanian, Mani
    McHutchison, John
    Benhamou, Yves
    Sulkowski, Mark
    Nelson, David R.
    Zeuzem, Stefan
    [J]. GASTROENTEROLOGY, 2010, 138 (05) : S847 - S847
12345